Klinikum Frankfurt Höchst GmbH; Klinik für Gynäkologie und Geburtshilfe
Frankfurt, Germany
General hospital in Frankfurt, Hessen
Gotenstraße 6-8, 65929 Frankfurt am Main
About Klinikum Frankfurt Höchst GmbH; Klinik für Gynäkologie und Geburtshilfe
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
2
Clinical Trials at Klinikum Frankfurt Höchst GmbH; Klinik für Gynäkologie und Geburtshilfe
During the past decade, Klinikum Frankfurt Höchst GmbH; Klinik für Gynäkologie und Geburtshilfe conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of a Combination of Trastuzumab and Capecitabine With or Without Pertuzumab in Patients With HER2-positive Metastatic Breast Cancer (PHEREXA)
2010-01-26
2017-08-07
Completed
452
A Study of the Efficacy and Safety of Atezolizumab Plus Chemotherapy for Patients With Early Relapsing Recurrent Triple-Negative Breast Cancer
2018-01-11
2024-01-31
Recruiting
572
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Klinikum Frankfurt Höchst GmbH; Klinik für Gynäkologie und Geburtshilfe
According to Clinical.Site data, the most researched conditions in "Klinikum Frankfurt Höchst GmbH; Klinik für Gynäkologie und Geburtshilfe" are
"Breast Cancer" (1 trials) and "Triple Negative Breast Neoplasms" (1 trials). Many other conditions were trialed in "Klinikum Frankfurt Höchst GmbH; Klinik für Gynäkologie und Geburtshilfe" in a lesser frequency.
Clinical Trials Intervention Types at Klinikum Frankfurt Höchst GmbH; Klinik für Gynäkologie und Geburtshilfe
Most popular intervention types in "Klinikum Frankfurt Höchst GmbH; Klinik für Gynäkologie und Geburtshilfe" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Capecitabine" (2 trials), "Atezolizumab" (1 trials), "Carboplatin" (1 trials), "Gemcitabine" (1 trials) and "Pertuzumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Klinikum Frankfurt Höchst GmbH; Klinik für Gynäkologie und Geburtshilfe
The vast majority of trials in "Klinikum Frankfurt Höchst GmbH; Klinik für Gynäkologie und Geburtshilfe" are
1 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Klinikum Frankfurt Höchst GmbH; Klinik für Gynäkologie und Geburtshilfe
Currently, there are NaN active trials in "Klinikum Frankfurt Höchst GmbH; Klinik für Gynäkologie und Geburtshilfe".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Klinikum Frankfurt Höchst GmbH; Klinik für Gynäkologie und Geburtshilfe,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Klinikum Frankfurt Höchst GmbH; Klinik für Gynäkologie und Geburtshilfe, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".